Vaccination

Austria to phase out AstraZeneca virus vaccine

Credit: CC0 Public Domain

Austria will phase out AstraZeneca from its COVID-19 immunisation programme because of delivery problems and wariness among the population following reports of the vaccine’s rare side effects, the health minister said.

Austria becomes the third European country to drop AstraZeneca, after Norway and Denmark ditched the vaccine over rare cases of severe blood clots in people receiving the jab.

“We will probably continue to do first shots with AstraZeneca until early June, and then that’s it… AstraZeneca will be discontinued,” Health Minister Wolfgang Mueckstein told private TV channel Puls 24 late Monday.

Mueckstein said those who received a first shot of AstraZeneca would still get a second shot of the vaccine, but officials would determine which other vaccine to use for any refresher jabs later.

Mueckstein, a doctor himself, insisted AstraZeneca was “safe” but said Austria had taken the decision to discontinue it because of “bad compliance among the population”, “bad press” and “delivery problems”.

The European Commission is suing the British-Swedish pharmaceutical group over its failure to deliver millions of doses of its vaccine.

A third of Austria’s nine million people has received at least one COVID-19 shot.

The European Medicines Agency and the World Health Organization both recommend continued use of the vaccine, arguing that the benefits far outweigh the associated risks.


Follow the latest news on the coronavirus (COVID-19) outbreak


© 2021 AFP

Citation:
Austria to phase out AstraZeneca virus vaccine (2021, May 18)
retrieved 18 May 2021
from https://medicalxpress.com/news/2021-05-austria-phase-astrazeneca-virus-vaccine.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Ad Block Detected

Welcome to Mediexpose, Please support our journalism by allowing ads. With support from readers like you, we can continue to deliver the best. You can support us free by simply allowing ads.